How to Get Xenpozyme (Olipudase Alfa-rpcp) Approved by Cigna in Texas: Complete Timeline, Forms, and Appeals Guide
Answer Box: Getting Xenpozyme Approved by Cigna in Texas
Cigna requires prior authorization for Xenpozyme (olipudase alfa-rpcp) with confirmed ASMD diagnosis through genetic testing and enzyme deficiency <10% of normal. Standard review takes 2-5 business days in Texas when complete documentation is submitted electronically via Express Scripts/Accredo specialty pharmacy.
Fastest path to approval:
- Verify coverage via Cigna member portal or call member services
- Gather evidence: SMPD1 genetic results, enzyme activity <10%, baseline imaging/labs
- Submit complete PA through specialist (geneticist/metabolic/pulmonologist) via CoverMyMeds or Cigna provider portal
Start today: Contact your specialist to confirm they have your genetic testing results and can initiate the prior authorization process.
Table of Contents
- Coverage Requirements at a Glance
- Step-by-Step: Fastest Path to Approval
- Texas Prior Authorization Timeline
- Common Denial Reasons & How to Fix Them
- Appeals Process in Texas
- Annual Renewal Requirements
- Cost Support Options
- Frequently Asked Questions
Coverage Requirements at a Glance
| Requirement | What It Means | Where to Find It | Source |
|---|---|---|---|
| Prior Authorization Required | Must get approval before treatment | All Cigna plans | Cigna PA Policy |
| Specialist Prescription | Geneticist, metabolic specialist, or pulmonologist | Provider credentials required | Cigna Coverage Criteria |
| Genetic Testing | Biallelic SMPD1 pathogenic variants | Lab report required | FDA Label |
| Enzyme Deficiency | <10% normal ASM activity | Leukocytes or fibroblasts | Cigna Policy IP-0500 |
| Non-CNS Disease Only | No central nervous system symptoms | Clinical documentation | Cigna Coverage Criteria |
| Specialty Pharmacy | Dispensed through Accredo/Express Scripts | Automatic routing post-approval | Express Scripts PA FAQ |
Step-by-Step: Fastest Path to Approval
1. Verify Your Cigna Coverage (Day 0)
Who does it: You or your clinic
What you need: Insurance card, member ID
How to submit: Call member services (number on card) or log into myCigna portal
Timeline: Same day
Source: Cigna Member Portal
2. Confirm Specialist Requirements (Day 0-1)
Who does it: Your care team
What you need: Appointment with qualified specialist
Required specialties: Geneticist, metabolic specialist, or pulmonologist experienced with ASMD
Timeline: Schedule within 1-2 weeks if new patient
Source: Cigna PA Requirements
3. Gather Required Documentation (Days 1-7)
Who does it: Specialist's office with your help
Essential documents:
- SMPD1 genetic testing results showing biallelic pathogenic variants
- ASM enzyme activity test showing <10% of normal
- Baseline imaging (spleen/liver measurements)
- Pulmonary function tests
- Complete blood count with platelets
- Weight-based dosing calculation
- Infusion monitoring plan
Timeline: 3-7 days if tests already completed
Source: Cigna Coverage Position
4. Submit Prior Authorization (Day 7-10)
Who does it: Specialist's office
How to submit: CoverMyMeds, Cigna provider portal, or Express Scripts portal
Required forms: Cigna PA form with complete clinical documentation
Timeline: Electronic submission processed within 2-3 business days
Source: Express Scripts PA Timeline
5. Track Status and Respond to Requests (Days 10-15)
Who does it: You and specialist's office
How to track: Cigna member portal, provider portal, or call member services
If more info requested: Respond within 3 business days to avoid delays
Timeline: Final decision within 5-14 business days
Source: Texas PA Requirements
Texas Prior Authorization Timeline
Under Texas state law, Cigna must respond to prior authorization requests within 3 business days for standard requests with complete documentation. If information is missing, they have 3 business days to notify you of what's needed, with a final decision deadline of 10 business days from the original request.
| Timeline | Standard Review | Expedited Review | Emergency |
|---|---|---|---|
| Complete submission | 3 business days | 72 hours | 24 hours |
| Missing info request | 3 business days | Same day | 1 hour |
| Final decision | 10 business days | 72 hours | 24 hours |
Source: Texas Insurance Code Requirements
Texas Gold Card Tip: If your specialist has a 90% prior authorization approval rate with Cigna over the past 12 months, they may be exempt from PA requirements for certain services under Texas's physician exemption law.
Common Denial Reasons & How to Fix Them
| Denial Reason | How to Overturn | Required Documents |
|---|---|---|
| Insufficient ASMD diagnosis | Resubmit complete genetic and enzyme testing | SMPD1 report + ASM activity <10% normal |
| Non-specialist prescriber | Add consultation letter from qualified specialist | Board certification in genetics, metabolism, or pulmonology |
| Missing baseline monitoring plan | Include detailed safety protocol | Infusion center protocols, vital sign monitoring, emergency procedures |
| Request for CNS symptoms | Clarify non-CNS disease only | Clinical notes documenting absence of neurological symptoms |
| Incomplete dosing justification | Provide weight-based calculations | Current weight, BSA if applicable, dose escalation schedule |
Source: Cigna Coverage Policy
Appeals Process in Texas
Internal Appeal (Level 1)
Timeline: File within 180 days of denial
Review time: 30 days (72 hours if expedited)
How to file: Online via myCigna portal, phone, or mail
Required: Copy of denial letter, medical records, specialist letter
Source: Cigna Appeals Process
External Review (Independent Review Organization)
When available: After internal appeal denial for medical necessity
Timeline: Request within 4 months of final internal denial
Review time: 20 days (5 days if expedited)
Cost: Free to patient (Cigna pays IRO)
Binding: Yes, Cigna must comply with IRO decision
Source: Texas Department of Insurance
From Our Advocates: We've seen Xenpozyme appeals succeed when families include both the genetic testing results and a detailed letter from their metabolic specialist explaining why enzyme replacement therapy is the only FDA-approved treatment for non-CNS ASMD symptoms. The key is demonstrating that supportive care alone isn't sufficient for this progressive disease.
Clinician Corner: Medical Necessity Letter Checklist
Healthcare providers should include these elements in letters supporting Xenpozyme approval:
Patient Information:
- Confirmed ASMD diagnosis with ICD-10 code E75.240
- Genetic testing results (biallelic SMPD1 pathogenic variants)
- ASM enzyme activity <10% of normal
Clinical Rationale:
- Non-CNS disease manifestations (splenomegaly, hepatomegaly, pulmonary involvement, thrombocytopenia)
- Baseline measurements and monitoring parameters
- Treatment goals and expected outcomes
Supporting Evidence:
- FDA approval for ASMD (no other approved therapies available)
- Published clinical trials demonstrating efficacy
- Professional guidelines supporting enzyme replacement therapy
Source: Xenpozyme Prescribing Information
Annual Renewal Requirements
Cigna requires annual reauthorization for Xenpozyme with evidence of sustained clinical benefit. Start the renewal process 60-90 days before expiration to prevent treatment gaps.
Required for Renewal:
- Updated letter of medical necessity
- Recent clinic notes (last 2-3 visits)
- Laboratory results (within 3 months)
- Imaging studies showing treatment response
- Documentation of continued medical necessity
- Infusion records and safety monitoring data
Timeline: Submit 60-90 days before expiration; standard review takes 30 days
Source: Cigna Renewal Requirements
Cost Support Options
Manufacturer Support:
- Sanofi Patient Connection Program
- Copay assistance for eligible patients
- Prior authorization support services
- Contact: Xenpozyme.com Patient Support
Foundation Assistance:
- National Organization for Rare Disorders (NORD)
- Patient Advocate Foundation
- Good Days (formerly Chronic Disease Fund)
- HealthWell Foundation
Texas-Specific Resources:
- Texas Health and Human Services (for Medicaid patients)
- 211 Texas (dial 2-1-1 for local assistance programs)
Frequently Asked Questions
Q: How long does Cigna prior authorization take for Xenpozyme in Texas?
A: Standard review takes 2-5 business days with complete documentation. Texas law requires decisions within 3 business days for complete submissions.
Q: What if Xenpozyme isn't on Cigna's formulary?
A: Request a formulary exception through your specialist. Since there are no FDA-approved alternatives for ASMD, coverage is often approved as medically necessary.
Q: Can I request an expedited review?
A: Yes, if treatment delay would jeopardize your health. Expedited reviews must be completed within 72 hours under Texas law.
Q: Do I need to try other treatments first (step therapy)?
A: No, Xenpozyme is the only FDA-approved treatment for ASMD. Step therapy typically doesn't apply to orphan drugs without alternatives.
Q: What happens if I move to Texas from another state?
A: Contact Cigna member services to transfer your prior authorization. Provide documentation from your previous state's approval.
Q: How much does Xenpozyme cost without insurance?
A: The wholesale acquisition cost ranges from $1,515 for a 4mg vial to $7,576 for a 20mg vial. Annual costs can exceed $300,000 depending on dosing.
Q: Can I appeal if my internal appeal is denied?
A: Yes, Texas offers external review through an Independent Review Organization (IRO) for medical necessity denials. The IRO's decision is binding on Cigna.
Q: Where can I get help with my appeal in Texas?
A: Contact the Texas Department of Insurance consumer helpline at 1-800-252-3439 or the Office of Public Insurance Counsel at 1-877-611-6742.
When Coverage Gets Complicated
When standard prior authorization processes aren't working, Counterforce Health helps patients and clinicians turn insurance denials into successful appeals. Their platform analyzes denial letters and payer policies to create targeted, evidence-backed rebuttals that address specific coverage criteria. For complex cases like Xenpozyme, where genetic testing and specialist documentation are crucial, having expert support can make the difference between approval and ongoing denials.
The service is particularly valuable for rare disease treatments where payers may not be familiar with the clinical evidence or may apply inappropriate criteria. Counterforce Health ensures appeals include the right medical literature, dosing justifications, and procedural requirements that Texas payers expect to see.
Sources & Further Reading
- Cigna Olipudase Coverage Policy IP-0500
- Cigna Xenpozyme Resource Guide
- Express Scripts Prior Authorization FAQ
- Texas Department of Insurance Appeals Guide
- Xenpozyme Prescribing Information
- Sanofi Patient Support Resources
- Texas Insurance Code PA Requirements
Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage decisions vary by individual plan and medical circumstances. Always consult with your healthcare provider and insurance plan for specific guidance. For assistance with Texas insurance regulations, contact the Texas Department of Insurance at 1-800-252-3439.
Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.